Latest News

Canadian Cardiovascular Society Receives $1.6 million to Study Myocarditis and/or Pericarditis after mRNA COVID-19 Vaccination

October 27, 2022

Today, at the Canadian Cardiovascular Congress where more than 1200 cardiovascular specialists and...

Two classes of glucose-lowering drugs reduce risk of heart failure, kidney complications and death – even in patients without type 2 diabetes

September 30, 2022

New Cardiorenal Protection Guideline urges use of GLP-1RA and SGLT2i drugs to save lives; as many as...

2023 Call for CCS Guideline and Clinical Practice Update Topics – NOW LIVE!

September 16, 2022

The CCS welcomes Seema Nagpal as our new Chief Science Officer

September 7, 2022

The Canadian Cardiovascular Society is pleased to announce that we are growing our leadership team...

Open call for CCS committee members

August 26, 2022

The CCS is comprised of members with an incredible range of skills, experience, interests, and...

Congratulations to the recipients of the 2022 CCS Recognition Awards

August 24, 2022

Each year, the CCS recognizes the outstanding achievements of individual Canadians and Canadian...

Report signals urgent need to invest in heart failure care

August 17, 2022

Our latest national report on the state of heart failure (HF) in Canada demonstrates that the30-day...

Top 10 Takeaways

July 28, 2022

Top 10 Takeaways from the 2021 CCS Guidelines for the Management of Dyslipidemia for the Prevention...

Sweeping dyslipidemia guidelines urge improved screening, new medications, and lifestyle counselling. But, hold the fish-oil supplements.

July 28, 2022

Aggressive new approaches to reduce cholesterol-related heart disease are part of an extensive...

You can now register for CCC 2022

July 7, 2022

We couldn’t be more excited to welcome you to our nation’s capital for our first in-person...